YARROW BIOSCIENCE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $156.00K, a 89.98% decline year-over-year.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was -$86.00K.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for fiscal 2021 was $46.82M, a 24.04% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for fiscal 2020 was $61.64M, a 310.65% increase from fiscal 2019.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for fiscal 2019 was $15.01M, a 88.03% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. stock issued during period, value, new issues for fiscal 2018 was $125.42M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | |
| 2023-03-31 | $156.00K 10-Q · filed 2024-05-09 | |
| 2022-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$24.83M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.56M 10-Q · filed 2023-05-11 | -$24.75M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $46.82M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$26.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $54.82M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | |
| 2021-03-31 | $73.13M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $61.64M 10-K · filed 2022-03-17 |
| 2020-06-30 | $53.65M 10-Q · filed 2020-08-06 | $160.47M derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-03-31 | $91.81M 10-Q · filed 2020-05-11 | $108.68M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $15.01M 10-K · filed 2021-03-04 |
| 2019-09-30 | $15.01M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $1.86M 10-Q · filed 2019-10-31 | |
| 2018-12-31 | $125.42M 10-K · filed 2020-03-03 | |
| 2018-06-30 | $27.00K 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $125.39M 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |